Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Journal of the American Heart Association|December 12, 2018
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialLeo Ungar, Robert M Clare, Fatima Rodriguez, et al.Journal of Clinical Pharmacology|July 24, 2015
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemiaJeremie H Estepp, Chiara Melloni, Courtney D Thornburg, et al.Journal of Clinical Pharmacology|July 19, 2019
Population Pharmacokinetics of Milrinone in Infants, Children, and AdolescentsChristoph P Hornik, Ram Yogev, Peter M Mourani, et al.European Heart Journal. Quality of Care & Clinical Outcomes|September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AFSean T Chen, Anne S Hellkamp, Richard C Becker, et al.American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.Circulation. Heart Failure|December 5, 2025
Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCMJuan Pablo Kaski, Paul F Kantor, Stephanie J Nakano, et al.Circulation. Cardiovascular Quality and Outcomes|July 9, 2015
Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 YearsKristian Kragholm, Sharif A Halim, Qinghong Yang, et al.Circulation|August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized TrialRenato D Lopes, Celestia S Higano, Susan F Slovin, et al.JAMA|May 12, 2011
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trialSamer S Najjar, Sunil V Rao, Chiara Melloni, et al.Circulation|May 29, 2008
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery diseaseMark Y Chan, Mauricio G Cohen, Christopher K Dyke, et al.Pageof 8